Back to search

Article

Systemic Inflammatory Indices as Accessible Biomarkers for Intracranial Outcome and Prognosis in Driver Gene-Negative NSCLC with Brain Metastases Treated with First-Line Chemoimmunotherapy

2025-11-05

Abstract excerpt

<title>Abstract</title> <p> Background For patients with driver gene-negative non-small cell lung cancer (NSCLC) with brain metastases, chemoimmunotherapy represents the standard treatment. However, the intracranial objective response rate (iORR) remains limited, highlighting the need for effective predictive biomarkers. This study aimed to evaluate the predictive value of systemic inflammatory indices, includin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e5515079-dff4-59d2-afa1-4a0d5f55a333
DOI
10.21203/rs.3.rs-7898869/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Systemic Inflammatory Indices as Accessible Biomarkers for Intracranial Outcome and Prognosis in Driver Gene-Negative NSCLC with Brain Metastases Treated with First-Line ChemoimmunotherapyDOI 10.21203/rs.3.rs-7898869/v1
The prognostic values of systemic immune-inflammation index and derived neutrophil-lymphocyte ratio in EGFR-mutant advanced non-small cell lung cancer.Semantic proximity
Characteristics and Hematological Indicators Predictors of Immunotherapy Response in Advanced Non-Small Cell Lung CancerSemantic proximity
Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis.Semantic proximity
Systemic immune-inflammation index predicts prognosis in patients with different EGFR-mutant lung adenocarcinoma.Semantic proximity
Prognostic value of the neutrophil-to-lymphocyte ratio and primary tumor location in patients with EGFR-mutated metastatic non-small cell lung cancer treated with TKIsNote: We found that we got a wrong results in the previous article. So, we checked our collected database and calculated again and corrected now.Semantic proximity
Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival.Semantic proximity
The Diagnostic Significance of Cellular Immune Inflammation Markers in Assessing Different Malignancy Grades GliomasSemantic proximity
The response predictive and prognostic values of systemic inflammation response index in patients with advanced lung adenocarcinomaSemantic proximity
Inflammatory markers including NLR, AFR and SII as prognostic factors in neuroblastomaSemantic proximity
The Brain-Lung Immunotherapy Prognostic (BLIP) Score: A Novel Robust Tool for Prognostication in Non-Small Cell Lung Cancer Patients with Brain MetastasesSemantic proximity
Brain Radiotherapy Combined with Immune Checkpoint Inhibitors and Chemotherapy as First-Line Treatment for Advanced Non-Small Cell Lung Cancer with Brain Metastases: A Retrospective StudySemantic proximity
Real-world survival outcomes to first-line chemoimmunotherapy and biomarker analysis in extensive-stage small-cell lung cancerSemantic proximity
Select a neighboring publication to make it the new centre.